APA (7th ed.) Citation

JH, L., RJ, A., D, L., Y, H., RA, A., M, T., . . . L, Z. (2026). Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant. Drug safety, 49(8), 985. https://doi.org/10.1007/s40264-026-01663-9

Chicago Style (17th ed.) Citation

JH, Lewis, Andrade RJ, Larrey D, Horsmans Y, Anderson RA, Trajanovic M, Groettrup-Wolfers E, and Zuurman L. "Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant." Drug Safety 49, no. 8 (2026): 985. https://doi.org/10.1007/s40264-026-01663-9.

MLA (9th ed.) Citation

JH, Lewis, et al. "Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant." Drug Safety, vol. 49, no. 8, 2026, p. 985, https://doi.org/10.1007/s40264-026-01663-9.